Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Multicentre Proof-of-concept Trial of IVA337 in the Treatment of Diffuse Cutaneous Systemic Sclerosis
Conditions
Interventions
IVA337
Placebo
Locations
49
Bulgaria
University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski
Pleven, Bulgaria
Multiprofile Hospital for Active Treatment Plovdiv
Plovdiv, Bulgaria
University Multiprofile Hospital for Active Treatment -Kaspela
Plovdiv, Bulgaria
University Multiprofile Hospital for Active Treatment - "Sveti Ivan Rilski"
Sofia, Bulgaria
Hôpital Pellegrin
Bordeaux, France
CHRU de Lille- Hôpital Claude Huriez
Lille, France
Start Date
October 29, 2015
Primary Completion Date
October 1, 2018
Completion Date
October 12, 2018
Last Updated
March 4, 2019
NCT05270668
NCT05626751
NCT04986605
NCT04478994
NCT06425653
NCT02374320
Lead Sponsor
Inventiva Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions